Can trimethoprim‑sulfamethoxazole (Bactrim) cause fever and a diffuse rash?

Can Bactrim Cause Fever and Widespread Rash?

Yes, Bactrim (trimethoprim-sulfamethoxazole) can absolutely cause fever and widespread rash, and this combination represents a potentially severe hypersensitivity reaction that requires immediate drug discontinuation. 1

Immediate Recognition and Action

The FDA label explicitly warns that patients developing rash, fever, or any sign of adverse reaction should stop taking Bactrim immediately and contact their healthcare provider as soon as possible 1. This presentation may represent:

• Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS syndrome) – typically manifests 2–8 weeks after drug initiation with fever, morbilliform rash, eosinophilia, and potential multiorgan dysfunction 2, 3
• SCoRCH syndrome (Sudden Conjunctivitis, Lymphopenia, and Rash Combined with Hemodynamic changes) – presents with generalized sunburn-like erythema, conjunctivitis, fever, hypotension, tachycardia, and lymphopenia, typically within 1 day in previously exposed patients or 4–11 days in treatment-naïve patients 4
• Simple hypersensitivity reaction – may progress to more severe manifestations if drug is continued 1

Critical Clinical Features to Assess

When evaluating a patient with fever and rash on Bactrim, immediately look for:

• Respiratory compromise (dyspnea, wheeze, stridor) indicating potential anaphylaxis 5
• Facial or airway angioedema – a danger sign that may progress to laryngeal edema 6
• Hypotension or tachycardia suggesting systemic involvement 4
• Conjunctivitis combined with sunburn-like erythema 4
• Eosinophilia (check CBC with differential) 2, 3, 7
• Elevated liver enzymes or creatinine indicating organ involvement 3, 7
• Lymphopenia (particularly in SCoRCH syndrome) 4
• Mucosal involvement with painful or burning lesions 5

Management Algorithm

Step 1: Discontinue Bactrim Immediately

• Stop the drug regardless of severity – this is non-negotiable 1, 2
• Document as a severe drug allergy in the medical record to prevent future exposure 6

Step 2: Classify Severity

• Severe reaction if ANY of the following are present: respiratory compromise, hypotension/syncope, airway angioedema, mucosal involvement, or evidence of organ dysfunction 5
• Non-severe if only isolated cutaneous findings without systemic features 5

Step 3: Initiate Treatment Based on Severity

For severe reactions:

• Diphenhydramine 25–50 mg IV or orally for acute symptom control 6
• Methylprednisolone 100 mg IV or prednisone 0.5–2 mg/kg orally 6
• Monitor for at least 4–6 hours for progression to anaphylaxis 6
• Continuously assess for respiratory compromise and hypotension 6

For DRESS syndrome specifically:

• High-dose systemic corticosteroids are required 8, 2, 3
• Monitor CBC with differential every 2–3 days and liver enzymes twice weekly 8
• Anticipate prolonged course requiring 3–6 months of treatment with potential flares during steroid taper 8
• Consider dermatology and allergy consultation for refractory cases 8

For non-severe reactions:

• Antihistamine therapy alone is sufficient 5

Special Populations at Higher Risk

The FDA label identifies that AIDS patients have significantly increased incidence of rash, fever, and leukopenia compared to non-AIDS patients when treated with Bactrim 1. This population requires particularly vigilant monitoring and lower threshold for drug discontinuation.

Common Pitfalls to Avoid

• Do not underestimate facial edema – it can rapidly evolve into life-threatening airway obstruction 6
• Do not rechallenge with Bactrim once a severe reaction has occurred 1
• Do not delay discontinuation while awaiting laboratory confirmation – clinical judgment is paramount 7
• Do not miss the delayed presentation – DRESS can occur 4.5 weeks after completing a course of Bactrim 7

Alternative Antibiotic Selection

When Bactrim must be replaced:

• For streptococcal infections in penicillin-allergic patients: clindamycin or doxycycline are appropriate alternatives 5
• For DRESS syndrome requiring ongoing antibiotic coverage: consider aztreonam or linezolid 8
• Avoid sulfonamide-containing drugs in the future 1

Documentation Requirements

Provide the patient with formal written documentation of the severe drug allergy for personal records and future healthcare encounters 6. This prevents inadvertent re-exposure across different healthcare systems.